Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Work In Process (2016 - 2017)

Integra Lifesciences Holdings' Work In Process history spans 7 years, with the latest figure at $47.3 million for Q3 2017.

  • For Q3 2017, Work In Process changed N/A year-over-year to $47.3 million; the TTM value through Sep 2017 reached $47.3 million, changed N/A, while the annual FY2016 figure was $50.0 million, N/A changed from the prior year.
  • Work In Process for Q3 2017 was $47.3 million at Integra Lifesciences Holdings, down from $50.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $54.7 million in Q2 2015 and bottomed at $47.3 million in Q3 2017.
  • The 4-year median for Work In Process is $50.1 million (2014), against an average of $50.5 million.